CAS 1435488-37-1: XMD17-109
Formula:C36H46N8O3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | XMD17 109 REF: IN-DA009CFRCAS: 1435488-37-1 | 98% | To inquire | Tue 04 Mar 25 |
 | XMD17-109 REF: TM-T1842CAS: 1435488-37-1 | 98.86% - 99.75% | 42.00 €~538.00 € | Tue 11 Mar 25 |
 | XMD17-109 REF: 54-BISN0221CAS: 1435488-37-1 | - - - | 182.00 €~1,514.00 € | Tue 11 Mar 25 |
 | XMD17-109 REF: 3D-KHC48837CAS: 1435488-37-1 | Min. 95% | To inquire | Tue 15 Apr 25 |
Ref: IN-DA009CFR
| 5mg | 99.00 € | ||
| 25mg | 249.00 € | ||
| 50mg | 561.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
XMD17-109
CAS:1435488-37-1
XMD17-109 (ERK5-IN-1) is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
Formula:
C36H46N8O3
Purity:
98.86% - 99.75%
Color and Shape:
Solid
Molecular weight:
638.8
Ref: TM-T1842
| 1mg | 42.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 144.00 € | ||
| 25mg | 221.00 € | ||
| 50mg | 359.00 € | ||
| 100mg | 538.00 € | ||
| 1mL*10mM (DMSO) | 110.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Ref: 54-BISN0221
| 10mg | 182.00 € | ||
| 25mg | 347.00 € | ||
| 50mg | 577.00 € | ||
| 100mg | 963.00 € | ||
| 250mg | 1,514.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
XMD17-109
CAS:1435488-37-1
XMD17-109 is a drug that inhibits the mitogen-activated protein kinase (MAPK) pathway, which is a …
Formula:
C36H46N8O3
Purity:
Min. 95%
Molecular weight:
638.8 g/mol
Ref: 3D-KHC48837
| 25mg | 901.00 € | ||
| 50mg | 1,357.00 € | ||
| 100mg | 1,889.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
